OOIR: Observatory of International Research

Papers

(The TQCC of Therapeutic Advances in Drug Safety is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Impact of different doses of esketamine on the incidence of hypotension in propofol-based sedation for colonoscopy: a randomized controlled trial	34
Age-stratified analysis of adverse event signals for clarithromycin: a disproportionality analysis using the FDA Adverse Event Reporting System	31
Safety of dipeptidyl peptidase-4 inhibitors in older adults with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials	26
Drug interactions in patients with alcohol use disorder: results from a real-world study on an addiction-specific ward	22
HIV/AIDS patients’ knowledge, attitude, and practice toward anti-retroviral therapy medications’ adverse effects and associated factors in Tikur Anbessa Specialized Hospital	17
Effect of heparin for the prevention of venous thromboembolism in patients with spontaneous intracranial cerebral hemorrhage: a meta-analysis	14
Patients’ views on Self-administration of Medication during hospitalisation: a mixed-methods study	12
Development and psychometric assessment of self-reported patient medication safety scale (SR-PMSS)	12
Inappropriate quetiapine use at a large academic medical center: frequency of misuse and associated costs of adverse effects	12
A disproportionality analysis for assessing the safety of FLT3 inhibitors using the FDA Adverse Event Reporting System (FAERS)	11
Interventions and impact of pharmacist-delivered services in perioperative setting on clinically important outcomes: a systematic review and meta-analysis	11
Adverse event profiles of CDK4/6 inhibitors: data mining and disproportionality analysis of the FDA adverse event reporting system	11
Ten-year trends in adverse drug reaction–related hospitalizations among people with dementia	11
Could chlorophyllins improve the safety profile of beta-d-N4-hydroxycytidine versus N-hydroxycytidine, the active ingredient of the SARS-CoV-2 antiviral molnupiravir?	10
Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge	10
Determinants of COVID-19 vaccine-induced myocarditis	10
Flow rate accuracy of infusion devices within healthcare settings: a systematic review	8
The 7th European Pharmacovigilance Congress: speaker abstracts	8
Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study	8
Association between number of medications and indicators of potentially inappropriate polypharmacy: a population-based cohort of older adults in Quebec, Canada	7
Development and validation of a risk-prediction model for adverse drug reactions in real-world cancer patients treated with anlotinib	7
Definition of self-medication: a scoping review	6
Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature	6
Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community	5
Safety of triazole antifungals: a pharmacovigilance study from 2004 to 2021 based on FAERS	5

Physiologically based pharmacokinetic modeling to predict the effect of risperidone on aripiprazole pharmacokinetics in subjects with different CYP2D6 genotypes and individuals with hepatic impairment	4
Physiologically based pharmacokinetic modeling of candesartan to predict the exposure in hepatic and renal impairment and elderly populations	4
Enhancing self-medication practices in the era of infodemic: the role of pharmacovigilance	4
Acceptability of a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice: a mixed methods study	4
Medication errors by caregivers in the homes of children discharged from a pediatric department in Ghana	4
Adverse drug events associated with capecitabine: a real-world pharmacovigilance study based on the FAERS database	4
Governance of artificial intelligence and machine learning in pharmacovigilance: what works today and what more is needed?	4
Effect of a closed-loop medication order executive system on safe medication administration at a tertiary hospital: a quasi-experimental study	4
Determining the optimum dose of remifentanil in combination with propofol for total intravenous anaesthesia in hysteroscopy under Narcotrend and SPI monitoring	4
Association of thrombopoietin-related drugs with thromboembolic events: Mendelian randomization and a real-world study	4